Genix Pharmaceuticals Corporation reported earnings results for the first quarter ended January 31, 2024. For the first quarter, the company reported revenue was CAD 0.000071 million compared to CAD 0.001582 million a year ago. Net loss was CAD 0.059058 million compared to CAD 0.227037 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | -16.67% | -16.67% | +150.00% |
1st Jan change | Capi. | |
---|---|---|
+150.00% | 2.15M | |
+13.21% | 8.15B | |
-0.47% | 7.23B | |
+12.30% | 6.65B | |
-6.99% | 3.72B | |
-7.95% | 3.64B | |
-4.78% | 1.31B | |
+12.61% | 972M | |
-43.32% | 863M | |
-22.54% | 799M |
- Stock Market
- Equities
- GENX Stock
- News Genix Pharmaceuticals Corporation
- Genix Pharmaceuticals Corporation Reports Earnings Results for the First Quarter Ended January 31, 2024